Mechanisms and treatment of dyslipidemia of renal diseases.

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Dyslipidemia is commonly observed in nephrotic syndrome, in chronic renal failure, and after renal transplantation. The patterns of dyslipidemia, however, differ among these three conditions, and the origins and mechanisms responsible for abnormalities in lipoprotein metabolism in each are not well understood. Whether these dyslipidemias contribute to the development of atherosclerosis and coronary heart disease is uncertain, but it is probable that they do. Important questions are whether an attempt should be made to treat the various renal dyslipidemias, and if so, by what means. Also of current interest are dyslipidemias in the nephrotic syndrome, chronic renal failure (uremia), and the post-renal transplantation state.

Original languageEnglish (US)
Pages (from-to)784-790
Number of pages7
JournalCurrent opinion in nephrology and hypertension
Issue number5
StatePublished - Sep 1993

ASJC Scopus subject areas

  • Internal Medicine
  • Nephrology


Dive into the research topics of 'Mechanisms and treatment of dyslipidemia of renal diseases.'. Together they form a unique fingerprint.

Cite this